FDA Warns Abiomed About Unlawful Promotion Of Impella Cardiac Pump

FDA says Abiomed is promoting its top-selling Impella 2.5 cardiac pump for unapproved uses, and sent a warning letter to the firm June 10.

More from Archive

More from Medtech Insight